Two-year PRISM results show 4D-150 gene therapy sustains wet AMD vision while cutting anti-VEGF injections up to 87%, with ...
SOL-1 results show intravitreal axitinib hydrogel delivered superior vision maintenance and anatomic outcomes through 52 weeks.
Ferrari is the co-inventor, with Prof Jorge Alió, of femtosecond laser-assisted annular keratopigmentation (FLAAK). In 2013, he performed the world's first eye colour change operation using ...
Talia R. Kaden, MD | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology Times, Modern ...
Wilmer Eye Institute, Johns Hopkins University, ...
Michael Mbagwu, MD | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology Times, Modern ...
Ophthalmology Times Europe | Journals | Ophthalmology Times Europe connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Eichenbaum about the cell and gene therapy pipeline ahead, what sustains a career in ...
Bausch + Lomb’s EyeGility preloaded enVista IOL inserter streamlines cataract surgery with push-plunger delivery, less handling, faster workflow. Bausch + Lomb has announced the US commercial launch ...
Louis R. Pasquale, MD, FARVO, is Shelley and Steven Einhorn Professor of Ophthalmology at Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai in New York, New York.
Kenneth C. Fan, MD, MBA, of Retina Consultants of Texas.
S. Robert Levine, MD, is founder and CEO of the Mary Tyler Moore Vision Initiative.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results